Made in China 2025 is the first 10-year strategic plan of China in building a strong power in manufacturing. The plan was made based on the new international and domestic environment aimed at improving the quality and level of China’s manufacturing industry. It is a blueprint for China’s plan to transform the country into a hi-tech powerhouse that dominates advanced industries like robotics, advanced information technology, aviation, and new energy vehicles.
Last year, China surpassed the U.S. and became the largest plug-in electric car markets in terms of total annual sales, China was therefore ranked as the best-selling plug-in electric passenger car country market in the world in 2015. With strong government support and relevant encouraging policies, China is on track to become the global leader in electric vehicle (EV) market. Below are the main reasons:-
1. Basic concepts & facts
Consolidated Report by ChinaAbout.net: Last night, China Chamber of Commerce for Import and Export of Machinery and Electronic Products (CCCME), China Photovoltaic Industry Alliance and five industrial organizations jointly published the “Joint statement of price agreement over Chinese photovoltaic products to be exported to the EU”, the full text in English version reads as follows:
Consolidated Report by ChinaAbout.net: According to Xinhua News Agency, Chinese President Xi Jinping recently visited the Wuhan East Lake National Innovation Demonstration Zone to review the development of the “China Optical Valley”. Xi inspected the relevant development of the optical fiber communications, 3D printing, biomass energy and other products and technologies. The Chinese general secretary was very pleased. He said that China shall not be a mere large economy, but it also shall be a strong economy. Prosperity of the country relies on independent innovation, technology, talents, and technology is the foundation for the national prosperity of China.
Consolidated Report by ChinaAbout.net: According to the Ministry of Public Security of the People’s Republic of China, recently, the Ministry of Public Security through unified actions in Changsha, Shanghai and Zhengzhou and other places identified that some executives of GlaxoSmithKline (China) InvestmentCo.Ltd, or GSK are suspected of serious economic crimes and legal investigation has been raised.
Public security organs have identified that in recent years, GlaxoSmithKline (China) Investment Co., Ltd. in order expand the sale channels in China has adopted methods including raising drug prices, the use of travel agencies, making direct bribery or other forms of sponsorship to individual government officials, pharmaceutical industry associations and hospitals and doctors. Meanwhile, fabricated VAT invoices issued by travel agencies are adopted by the company in committing criminal activities.
In addition, the public security organs have identified that some executives of GlaxoSmithKline (China) Investment Co., are suspected of taking rebates, commissions and other forms of taking bribes.
Currently, the public security organs have adopted criminal compulsory actions against relevant suspects of GlaxoSmithKline (China) Investment Co., Ltd. and related travel agencies according to the law. After initial interrogation, the suspects have made confession to the crimes. The case is still under further investigation .